Users' Handbook supplement to the Guidance Document for developing and assessing Adverse Outcome Pathways [electronic resource].
Material type:![Article](/opac-tmpl/lib/famfamfam/AR.png)
Item type | Home library | Collection | Call number | Status | Date due | Barcode | Item holds | |
---|---|---|---|---|---|---|---|---|
Working Paper | Biblioteca Digital | Colección OECD | OECD 5jlv1m9d1g32-en (Browse shelf(Opens below)) | Not For Loan |
Collection: Colección OECD Close shelf browser (Hides shelf browser)
This document is a supplement to the Guidance Document for developing and assessing Adverse Outcome Pathways (AOPs). It provides focused and practical instructions for both AOP developers and reviewers and is intended to assist in identifying, organising and evaluating critical information on key events (KEs) as well as linkages between KEs within the AOP (i.e. AOP development). It also provides explicit guidance on how to assess the weight of evidence (WoE) supporting the overall AOP and its relevance for life stage, sex and taxonomy (i.e. AOP evaluation). This handbook is not intended to provide a review or summary of the literature informing the AOP concept. Instead, it focuses on practical aspects of AOP development and assessment. It has been developed by a subgroup of the OECD Extended Advisory Group for Molecular Screening and Toxicogenomics (EAGMST).
There are no comments on this title.